A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
NCT00268827 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2007-04-05
Summary
The purpose of this study is to compare Kaletra tablets with Kaletra soft-gel capsules to see if there is any change in the side effects you may have and to see how people in the study feel about using the tablets.
Conditions
- HIV-1
- AIDS
Interventions
- DRUG
-
Kaletra soft-gel capsules switched to Kaletra tablets
- DEVICE
-
MOS-HIV Health and Medication Satisfaction Survey, Global Conditioning Improvement and Therapy Preference Questionnaire
Sponsors & Collaborators
-
AIDS Arms Inc.
lead OTHER
Principal Investigators
-
Marsden K. Rawlings, MD · AIDS Arms Inc./Peabody Health Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Completion
- 2006-02-28
Countries
- United States
Study Locations
More Related Trials
-
GW873140 In Combination With Kaletra In HIV Infected Subjects
NCT00102778 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
NCT00234923 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
NCT00648999 ·Status: COMPLETED ·Phase: PHASE4
-
Kaletra-isentress Treatment Evaluation
NCT00700115 ·Status: COMPLETED ·Phase: PHASE4
-
GSK706769/KALETRA Drug-drug Interaction Study
NCT00723775 ·Status: COMPLETED ·Phase: PHASE1
-
High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
NCT00247143 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
NCT00234910 ·Status: COMPLETED ·Phase: PHASE3
-
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
NCT00443703 ·Status: TERMINATED ·Phase: PHASE3
-
Lopinavir Capsules to Kaletra or Invirase Tablets
NCT00438152 ·Status: COMPLETED ·Phase: PHASE4
-
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
NCT00443729 ·Status: TERMINATED ·Phase: PHASE3
-
Kaletra Monotherapy in HIV/HCV Co-infected Subjects
NCT00508222 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Liquid Kaletra and Low Dose Kaletra Tablets
NCT00762320 ·Status: COMPLETED ·Phase: NA
-
Raltegravir Kaletra Pharmacokinetics
NCT00564772 ·Status: COMPLETED ·Phase: PHASE4
-
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
NCT00192621 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients
NCT00116636 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Use Investigation of Kaletra
NCT01076972 ·Status: COMPLETED
-
The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine
NCT07131826 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
NCT01103596 ·Status: COMPLETED
-
Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens
NCT00052117 ·Status: COMPLETED ·Phase: PHASE2
-
Kaletra and Viread in Antiretroviral Naïve Patients
NCT00679926 ·Status: TERMINATED ·Phase: PHASE4
-
FREE Study: Efficacy and Toxicity of Trizivir
NCT00405925 ·Status: COMPLETED ·Phase: PHASE3
-
TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.
NCT00258557 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Effects of Switching Kaletra to Boosted Reyataz
NCT00413153 ·Status: COMPLETED ·Phase: NA
-
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
NCT00085943 ·Status: COMPLETED ·Phase: PHASE3
-
Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program
NCT01662336 ·Status: COMPLETED